Table 2 The distribution of urinary Atyp.C, N.SEC, SEC, and WBC in different pathological types of BC (/ul).

From: The UF-5000 Atyp.C parameter is an independent risk factor for bladder cancer

Blandder cancer grade

N (%)

Age, years (IQR)

Gender (M/F)

Atyp.C (IQR)

N.SEC (IQR)

SEC (IQR)

WBC (IQR)

HMIBC

48

64 (59, 73)

38/10

0.5 (0.1, 1.53)

8 (2.05, 19.33)

11.35 (5.43, 32.6)

119.5 (34.4, 317.5)

HNMIBC

34

65 (58, 73)

23/11

0.2 (0.1, 1.35)

5.2 (2.23, 10.78)

7.5 (3.38, 16.6)

126.15 (21.33, 546.8)

LMIBC

9

65 (57, 79)

7/2

0.6 (0, 1.4)

1.4 (1.3, 3.1)

3.8 (1.7, 11.9)

26 (15.6, 95.8)

LNMIBC

63

64 (55, 73)

54/9

0 (0, 0.35)

2.9 (1.15, 7.5)

4.4 (1.65, 9.85)

50.9 (11.45, 144)

PUNLMP

29

60 (53, 68)

22/7

0.1 (0, 0.7)

2.4 (1.2, 8.6)

5.3 (1.8, 9.4)

16.1 (4.2, 262.7)

PUCII

28

67 (57, 75)

18/10

0.1 (0, 1.45)

5.1 (2.1, 11.2)

8.25 (3.83, 26.18)

107.85 (41.55, 377.68)

Other

pathological types

26

63 (57, 71)

20/6

0.05 (0, 0.275)

3 (1.53, 11.43)

6.95 (2.13, 20.05)

47.75 (22.98, 182.6)

Total

237

64 (57, 73)

182/55

0.1(0, 0.8)

4.4 (1.5, 10.9)

6.7 (2.4, 17.8)

68.6 (18.3, 268.9)

  1. M/F, male/famle; SEC, squamous epithelial cells; N.SEC, non-squamous epithelial cells; WBC, white blood cell; IQR, interquartile range; HMIBC, high-grade muscle invasive bladder cancer; HNMIBC, high-grade non-muscle invasive bladder cancer; LMIBC, low-grade muscle invasive bladder cancer; LNMIBC, low-grade non-muscle-invasive bladder cancer; PUNLMP, papillary urothelial neoplasm of low malignant potential; PUCII, papillary urothelial carcinoma grade II bladder cancer; BC, bladder carcinoma.